Clinical Trials on Chronic Hepatitis C Virus (HCV) Infection Genotype 1 in Japan
Total 95 results
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University; Yamanashi...Recruiting
-
Mitsubishi Tanabe Pharma CorporationToray Industries, IncCompleted
-
NovartisCompletedChronic Hepatitis CJapan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Norte Study GroupMerck Sharp & Dohme LLCUnknown
-
AbbottAbbott Japan Co.,LtdCompleted
-
Bristol-Myers SquibbCompletedChronic Hepatitis CJapan
-
Mitsubishi Tanabe Pharma CorporationVertex Pharmaceuticals IncorporatedCompleted
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Belgium, Canada, Germany, Japan, Puerto Rico, Russian Federation, Spain, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationVertex Pharmaceuticals IncorporatedCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedChronic Hepatitis CJapan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Japan Liver Oncology GroupUnknownChronic Hepatitis B | Chronic Hepatitis CJapan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Chugai PharmaceuticalCompleted
-
AbbVieRecruitingHepatitis C Virus (HCV)Japan
-
AbbVieCompletedHepatitis C Virus (HCV)Japan
-
Kindai UniversityUnknownChronic Hepatitis B | Chronic Hepatitis CJapan
-
Gilead SciencesCompleted
-
Bristol-Myers SquibbCompletedHepatitis C Virus InfectionJapan
-
Chugai PharmaceuticalCompletedLiver Cirrhosis | Chronic Hepatitis CJapan
-
Kyoto UniversityCompleted
-
Janssen Pharmaceutical K.K.Completed
-
Boehringer IngelheimCompleted
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedHepatitis C, ChronicJapan
-
AbbVieCompletedChronic Hepatitis C VirusJapan
-
Janssen Pharmaceutical K.K.Completed
-
AbbVieCompletedChronic Hepatitis C VirusJapan
-
GlaxoSmithKlineCompletedHepatitis C, ChronicJapan
-
Kyushu UniversityUnknown
-
Janssen Pharmaceutical K.K.Completed
-
Kyushu UniversityMerck Sharp & Dohme LLCCompletedChronic Kidney Disease stage3 | Hepatitis C ViralJapan
-
Janssen Pharmaceutical K.K.CompletedHepatitis C, ChronicJapan
-
Bristol-Myers SquibbCompleted
-
Kyoto UniversityCompleted
-
Bristol-Myers SquibbCompleted
-
Komagome HospitalJapan Agency for Medical Research and Development; Prism Pharma Co., Ltd.CompletedHepatitis C Virus-infected CirrhosisJapan
-
Komagome HospitalJapan Agency for Medical Research and Development; Prism Pharma Co., Ltd.Completed
-
Gilead SciencesCompleted
-
Bristol-Myers SquibbCompletedHepatitis C InfectionJapan
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, France, Japan, Spain, Sweden, Canada, Germany, Mexico, Denmark, Italy, Korea, Republic of, Taiwan, Argentina, Brazil, Ireland, Poland, Puerto Rico, United Kingdom
-
Gilead SciencesCompletedHepatitis C Virus InfectionJapan
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionJapan
-
Bristol-Myers SquibbCompletedHepatitis C Virus (HCV)Australia, Belgium, France, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Taiwan, United States, Chile, Hong Kong, Argentina, Netherlands, United Kingdom, Singapore, New Zealand, Finland, Greece
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Austria, Belgium, Canada, France, Germany, Japan, Portugal, Puerto Rico, Spain, Switzerland, United Kingdom
-
Gilead SciencesChugai PharmaceuticalCompletedHepatitis C Virus InfectionJapan
-
Gilead SciencesCompletedHIV-1/HBV Co-InfectionSpain, Taiwan, Korea, Republic of, Thailand, Hong Kong, Japan, France, Turkey, Puerto Rico, Malaysia, United States, China, Dominican Republic, Greece
-
AbbottAbbott Japan Co.,LtdCompleted